MedTrace Logo

Cholecalciferol for Vitamin D in Adult Cystic Fibrosis (CF) Patients

NCT00685971 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2014-11-21

No results posted yet for this study

Summary

The main aim of the research question to test the primary hypothesis of this study, namely, Does 12 weeks of an additional 5000 IU daily of cholecalciferol increase serum 25OHD levels in adults with Cystic Fibrosis (CF) who have vitamin D deficiency relative to placebo?

Conditions

Interventions

DIETARY_SUPPLEMENT

5000 IU of cholecalciferol

5 drops taken once daily for 12 weeks

DIETARY_SUPPLEMENT

placebo

5 drops once daily for 12 weeks

Sponsors & Collaborators

  • Unity Health Toronto

    lead OTHER

Principal Investigators

  • Anne Stephenson, Dr. · Unity Health Toronto

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2013-07-31
Completion
2013-07-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00685971 on ClinicalTrials.gov